AlphaYouArbutus Biopharma Corp: Roivant Sciences Ltd. discloses securities transactions
By AlphaYouPublished Form 4
Public disclosure
Roivant Sciences Ltd.
Reported activity
Roivant Sciences Ltd.
Reporting filer
Roivant Sciences Ltd. reported Disposition to issuer in Arbutus Biopharma Corp: 8967383 units of Common Shares, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Roivant Sciences Ltd. | 2026-10-01 | D | Disposition to issuer | 8967383 | 5.00 | 29,880,079 | 5 days | Filed terms
|
Common Shares
- Owner
- Roivant Sciences Ltd.
- Date
- 2026-10-01
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 8967383
- Price
- 5.00
- Following holdings
- 29,880,079
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: false
- transaction Shares: 8967383
- transaction Price Per Share: 5.00
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 29880079
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Roivant Sciences Ltd.: Director, 10% owner.
Original sources
Prepared automatically from public filing data. Report a correction.